Oligon

Scottsdale, United States

Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.

$14.0M raised

Sep 2025

Venture - Series Unknown

Top Investors

Fonds de solidarité FTQCTI Life Sciences FundInvestissement Quebec

19,000+ verified contacts

Emails, phones & LinkedIn profiles

How much funding has Oligon raised?

Oligon has raised $14.0M in total funding. The most recent round was Venture - Series Unknown. The last funding was announced in September 2025.

Who are Oligon's investors?

Oligon's investors include Fonds de solidarité FTQ, CTI Life Sciences Fund, Investissement Quebec.

Where is Oligon headquartered?

Oligon is headquartered in Scottsdale, United States.

What does Oligon do?

Oligon is an emerging biotechnology company developing a novel class of multimodal RNA therapeutics.

What stage is Oligon at?

Oligon is at the Venture - Series Unknown stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated September 23, 2025.

MLA

"Oligon — Funding & Investors." VCBacked, September 23, 2025, https://www.vcbacked.co/company/oligon. Accessed June 22, 2026.

APA

VCBacked. (2025). Oligon — Funding & Investors. Retrieved June 22, 2026, from https://www.vcbacked.co/company/oligon

Wikipedia (cite web)

{{cite web |title=Oligon — Funding & Investors |url=https://www.vcbacked.co/company/oligon |website=VCBacked |access-date=June 22, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated September 23, 2025.